OCMLDONCOSIL MED LTD.

About ONCOSIL MED LTD. (OCMLD)

ONCOSIL MED LTD. (OCMLD) is a N/A company headquartered in Macquarie Park, NSW, Australia whose shares trade over-the-counter on the Pink tier.

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy.

OCMLD key facts

Ticker symbol

OCMLD

Market tier

Pink

Headquarters

Macquarie Park, NSW, Australia

Shares outstanding

2,219,392,243

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Explore more: Pink stocks · OTC stocks starting with O